Clinical Trial Update: LATAM LOWERS LDL-C [Phase 4]

View source ↗

Summary

Novartis is conducting a Phase 4 trial in Latin America to lower LDL-C in individuals with hypercholesterolemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypercholesterolaemia | Phase 4 | Status: RECRUITING